[Construction norms for the tiered diagnosis and treatment and standardized management center of metabolic-associated fatty liver disease]. [PDF]
Fatty Liver and Alcoholic Liver Disease Study Group +2 more
europepmc +1 more source
[Fibroblast growth factor 21 improves alcoholic liver disease by regulating gut microbiota in mice]. [PDF]
Wu GC +5 more
europepmc +1 more source
[A case of neonatal fatty acid oxidation disorder]. [PDF]
Deng LL +4 more
europepmc +1 more source
[Value of Multivariate Computed Tomography Angiography for Predicting Major Adverse Cardiac Events in Patients With Coronary Artery Heart Disease]. [PDF]
Tu B +9 more
europepmc +1 more source
[Ultrasound technologies' new clinical application for chronic liver diseases]. [PDF]
Xiao MY, Lu X, Jin JY, Wu ML, Ren J.
europepmc +1 more source
[Development and validation of a machine learning-based prediction model for fatty liver in Wilson disease]. [PDF]
Shi S +6 more
europepmc +1 more source
肥育牛の血漿のHDL,LDL,TG,TCho,Echo,LPO,NEFAなどの脂質,GH,Cort,Insu,TSH,T4,T3,LHなどのホルモン,総蛋白質,Ca,Mg,無機リンなどの濃度を測定した. 血漿HDL濃度は第8-9肋間におけるロース芯の脂肪交雑値(サシ)と正の相関があり,またTChoとは有意な非常に高い正相関がある. 一方,高脂肪交雑牛ではHDLはLPOとも有意な高い正相関があった.
和田, 宏 +3 more
core
[Multiple clinical effects of recombinant human growth hormone therapy]. [PDF]
Zhou B, Yang Y.
europepmc +1 more source
[Natural history and risk factors of metabolic associated fatty liver disease in Chinese cohorts]. [PDF]
Zhang J, Zhan RX, Wang Y, Nan YM.
europepmc +1 more source
本研究使用大豆蛋白、鈣等材料,設計一大豆蛋白複合配方作為樣品,在倉鼠模式下探討樣品調節血脂之能力,將倉鼠分成5組,餵予普通飼料(C)、高脂飼料(HF) (含14%油脂、0.2%膽固醇)及添加低(0.5X)、中(1X)及高(2X)劑量樣品之高脂飼料共8週。 實驗結果顯示,相較於高脂飼料組(HF),中劑量(1X)與高劑量(2X)組可顯著(p < 0.05)降低血清三酸甘油酯濃度約22-24%,血清總膽固醇濃度下降約15-22%,血清低密度脂蛋白膽固醇濃度減少約26-37%,此外,與高脂控制組(HF)相比 ...
Zhi-Yi Yu, 余芝儀
core

